Watch our CPD-accredited webinar
Difficult-to-treat and severe asthma: changing the paradigm
to find out about new therapies, and how to identify and manage
difficult-to-treat and severe asthma.
The definition of neuropathic pain has changed
and opioids have been relegated to third-line therapy.
Read the latest Australian Prescriber article to find out more.
The latest RADAR discusses insulin glargine 300 IU/mL solution (Gla-300),
a basal insulin, administered subcutaneously once daily.
Read full article
Many factors contribute to achieving the best outcomes for
patients with rheumatoid arthritis:
early diagnosis and treatment initiation, treatment with
low-dose methotrexate, and structured collaboration
between patients, GPs, rheumatologists
and other healthcare professionals.
Find out more